Children were found to exhibit distinct type 1 diabetes endotypes compared with older adolescents; DNA testing has shown to be beneficial but controversial when personlizing care for patients with breast cancer; artifical intelligence (AI) usage across healthcare.
In a study published in Diabetologia, researchers found that children younger than 7 years diagnosed with type 1 diabetes have a different endotype from those diagnosed at 13 years or older. Reported on by MedPage Today, the study analyzed pancreas samples derived from the child participants, revealing distinct patterns of proinsulin localization that were not as evident in the older group. “Our results strongly suggest that type 1 diabetes exists as distinct conditions that segregate according to age at diagnosis and are distinguishable histologically,” said the study authors.
As DNA testing use grows to examine potential hereditary risks in breast cancer, a piece published in the The Washington Post discusses how even though these tests have led to the detection of a significant number of cancer-causing mutations, they have also contributed to potentially unnecessary surgeries. Initially, only the BRCA1 and BRCA2 mutations were tested, but now 30 to 80 cancer genes can be examined at a time, which may or may not have distinguishable cancer risks.
The use of artificial intelligence (AI) has led to several innovations within healthcare, such as faster diagnosis, automated claims processing, and accelerated development by pharmaceutical companies, among other advancements reported in Forbes. Additionally, ethical AI—when AI is used correctly and ethically—allows for greater accountability, traceability, and sustainability, which can assist in defining which AI use cases are and are not acceptable.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Homelessness Compounds Hospital Stay Challenges: Study Reveals Prolonged Discharge Struggles
March 28th 2024In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a homeless population, and whether age and/or injury severity had an influence on that relationship—with implications for improving the discharge process for these patients.
Read More
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More